Chlamydia trachomatis co-opts the FGF2 signaling pathway to enhance infection

PLoS Pathogens

Volumn 7, Issue 10, 2011, Pages

  Kim, Jung Hwa ^a,b   Jiang, Shaobo ^a,b   Elwell, Cherilyn A ^a,b   Engel, Joanne N ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEASOME; PROTEOHEPARAN SULFATE; INTERLEUKIN 1BETA CONVERTING ENZYME; PLATELET DERIVED GROWTH FACTOR RECEPTOR; SMALL INTERFERING RNA;

ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; CELL DEATH; CELL DIVISION; CELL SURFACE; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; ENZYME ACTIVATION; HOST CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; MOLECULAR WEIGHT; NONHUMAN; PHAGOCYTE; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; CELL VACUOLE; CHLAMYDIASIS; GENETIC TRANSCRIPTION; GENETICS; HELA CELL; METABOLISM; MICROBIOLOGY; PATHOGENICITY; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

BACTERIA (MICROORGANISMS); CHLAMYDIA TRACHOMATIS;

CASPASE 1; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FIBROBLAST GROWTH FACTOR 2; HELA CELLS; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 3; PROTEIN BINDING; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; UP-REGULATION; VACUOLES;

EID: 80055088874     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002285     Document Type: Article

References (73)

1. Mandell GL, Bennett JE, Dolin R, (2010) Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 7th ed. Philadelphia, PA Churchill Livingstone/Elsevier pp. 1 online resource (2 v. (cl, 4028, xcvii p.)).
2. Moulder JW, (1991) Interaction of chlamydiae and host cells in vitro. Microbiol Rev 55: 143-190.
3. Dautry-Varsat A, Subtil A, Hackstadt T, (2005) Recent insights into the mechanisms of Chlamydia entry. Cell Microbiol 7: 1714-1722.
4. Cocchiaro JL, Valdivia RH, (2009) New insights into Chlamydia intracellular survival mechanisms. Cell Microbiol 11: 1571-1578.
5. Elwell CA, Ceesay A, Kim JH, Kalman D, Engel JN, (2008) RNA interference screen identifies Abl kinase and PDGFR signaling in Chlamydia trachomatis entry. PLoS Pathog 4: e1000021.
6. Clifton DR, Fields KA, Grieshaber SS, Dooley CA, Fischer ER, et al. (2004) A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. Proc Natl Acad Sci U S A 101: 10166-10171.
7. Jewett TJ, Miller NJ, Dooley CA, Hackstadt T, (2010) The conserved Tarp actin binding domain is important for chlamydial invasion. PLoS Pathog 6: e1000997.
8. Hackstadt T, (2000) Redirection of host vesicle trafficking pathways by intracellular parasites. Traffic 1: 93-99.
9. Hybiske K, Stephens RS, (2007) Mechanisms of host cell exit by the intracellular bacterium Chlamydia. Proc Natl Acad Sci U S A 104: 11430-11435.
10. Xia M, Bumgarner RE, Lampe MF, Stamm WE, (2003) Chlamydia trachomatis infection alters host cell transcription in diverse cellular pathways. J Infect Dis 187: 424-434.
11. Fukuda EY, Lad SP, Mikolon DP, Iacobelli-Martinez M, Li E, (2005) Activation of lipid metabolism contributes to interleukin-8 production during Chlamydia trachomatis infection of cervical epithelial cells. Infect Immun 73: 4017-4024.
12. Hvid M, Baczynska A, Deleuran B, Fedder J, Knudsen HJ, et al. (2007) Interleukin-1 is the initiator of Fallopian tube destruction during Chlamydia trachomatis infection. Cell Microbiol 9: 2795-2803.
13. Chen JC, Zhang JP, Stephens RS, (1996) Structural requirements of heparin binding to Chlamydia trachomatis. J Biol Chem 271: 11134-11140.
14. Chen JC, Stephens RS, (1994) Trachoma and LGV biovars of Chlamydia trachomatis share the same glycosaminoglycan-dependent mechanism for infection of eukaryotic cells. Mol Microbiol 11: 501-507.
15. Chen JC, Stephens RS, (1997) Chlamydia trachomatis glycosaminoglycan-dependent and independent attachment to eukaryotic cells. Microb Pathog 22: 23-30.
16. Esko JD, Lindahl U, (2001) Molecular diversity of heparan sulfate. J Clin Invest 108: 169-173.
17. Bishop JR, Schuksz M, Esko JD, (2007) Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446: 1030.
18. Yu PJ, Ferrari G, Galloway AC, Mignatti P, Pintucci G, (2007) Basic fibroblast growth factor (FGF-2): the high molecular weight forms come of age. J Cell Biochem 100: 1100-1108.
19. Klagsbrun M, Smith S, Sullivan R, Shing Y, Davidson S, et al. (1987) Multiple forms of basic fibroblast growth factor: amino-terminal cleavages by tumor cell- and brain cell-derived acid proteinases. Proc Natl Acad Sci U S A 84: 1839-1843.
20. Schafer T, Zentgraf H, Zehe C, Brugger B, Bernhagen J, et al. (2004) Unconventional secretion of fibroblast growth factor 2 is mediated by direct translocation across the plasma membrane of mammalian cells. J Biol Chem 279: 6244-6251.
21. Temmerman K, Ebert AD, Muller HM, Sinning I, Tews I, et al. (2008) A direct role for phosphatidylinositol-4,5-bisphosphate in unconventional secretion of fibroblast growth factor 2. Traffic 9: 1204-1217.
22. Padera R, Venkataraman G, Berry D, Godavarti R, Sasisekharan R, (1999) FGF-2/fibroblast growth factor receptor/heparin-like glycosaminoglycan interactions: a compensation model for FGF-2 signaling. FASEB J 13: 1677-1687.
23. Roghan M, Mansukhani A, Dell'Era P, Bellosta P, Basilico C, et al. (1994) Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. J Biol Chem 269: 3976-3984.
24. Spivack-Kroizman T, Lemmon MA, Dikic I, Ladbury JE, Pinchasi D, et al. (1994) Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell 79: 1015-1024.
25. Zhang Y, McKeehan K, Lin Y, Zhang J, Wang F, (2008) Fibroblast growth factor receptor 1 (FGFR1) tyrosine phosphorylation regulates binding of FGFR substrate 2alpha (FRS2alpha) but not FRS2 to the receptor. Mol Endocrinol 22: 167-175.
26. Gotoh N, (2008) Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins. Cancer Sci 99: 1319-1325.
27. Taraktchoglou M, Pacey AA, Turnbull JE, Eley A, (2001) Infectivity of Chlamydia trachomatis serovar LGV but not E is dependent on host cell heparan sulfate. Infect Immun 69: 968-976.
28. Berry D, Kwan CP, Shriver Z, Venkataraman G, Sasisekharan R, (2001) Distinct heparan sulfate glycosaminoglycans are responsible for mediating fibroblast growth factor-2 biological activity through different fibroblast growth factor receptors. FASEB J 15: 1422-1424.
29. Saxena K, Schieborr U, Anderka O, Duchardt-Ferner E, Elshorst B, et al. (2010) Influence of heparin mimetics on the assembly of the FGF- FGFR4 signaling complex. J Biol Chem 285: 26628-26640.
30. Kan M, Wu X, Wang F, McKeehan WL, (1999) Specificity for fibroblast growth factors determined by heparan sulfate in a binary complex with the receptor kinase. J Biol Chem 274: 15947-15952.
31. Chen PY, Simons M, Friesel R, (2009) FRS2 via fibroblast growth factor receptor 1 is required for platelet-derived growth factor receptor beta-mediated regulation of vascular smooth muscle marker gene expression. J Biol Chem 284: 15980-15992.
32. Rodel J, Woytas M, Groh A, Schmidt KH, Hartmann M, et al. (2000) Production of basic fibroblast growth factor and interleukin 6 by human smooth muscle cells following infection with Chlamydia pneumoniae. Infect Immun 68: 3635-3641.
33. Prochnau D, Rodel J, Hartmann M, Straube E, Figulla HR, (2004) Growth factor production in human endothelial cells after Chlamydia pneumoniae infection. Int J Med Microbiol 294: 53-57.
34. Vlotides G, Chen YH, Eigler T, Ren SG, Melmed S, (2009) Fibroblast growth factor-2 autofeedback regulation in pituitary folliculostellate TtT/GF cells. Endocrinology 150: 3252-3258.
35. Bae YH, Bae MK, Kim SR, Lee JH, Wee HJ, et al. (2009) Upregulation of fibroblast growth factor-2 by visfatin that promotes endothelial angiogenesis. Biochem Biophys Res Commun 379: 206-211.
36. Su H, McClarty G, Dong F, Hatch GM, Pan ZK, et al. (2004) Activation of Raf/MEK/ERK/cPLA2 signaling pathway is essential for chlamydial acquisition of host glycerophospholipids. J Biol Chem 279: 9409-9416.
37. Coombes BK, Mahony JB, (2002) Identification of MEK- and phosphoinositide 3-kinase-dependent signalling as essential events during Chlamydia pneumoniae invasion of HEp2 cells. Cell Microbiol 4: 447-460.
38. Buchholz KR, Stephens RS, (2007) The extracellular signal-regulated kinase/mitogen-activated protein kinase pathway induces the inflammatory factor interleukin-8 following Chlamydia trachomatis infection. Infect Immun 75: 5924-5929.
39. Buchholz KR, Stephens RS, (2008) The cytosolic pattern recognition receptor NOD1 induces inflammatory interleukin-8 during Chlamydia trachomatis infection. Infect Immun 76: 3150-3155.
40. Vignola MJ, Kashatus DF, Taylor GA, Counter CM, Valdivia RH, (2010) cPLA2 regulates the expression of type I interferons and intracellular immunity to Chlamydia trachomatis. J Biol Chem 285: 21625-21635.
41. Gurumurthy RK, Maurer AP, Machuy N, Hess S, Pleissner KP, et al. (2010) A loss-of-function screen reveals Ras- and Raf-independent MEK-ERK signaling during Chlamydia trachomatis infection. Sci Signal 3: ra21.
42. Mehlitz A, Banhart S, Maurer AP, Kaushansky A, Gordus AG, et al. (2010) Tarp regulates early Chlamydia-induced host cell survival through interactions with the human adaptor protein SHC1. J Cell Biol 190: 143-157.
43. Conte C, Riant E, Toutain C, Pujol F, Arnal JF, et al. (2008) FGF2 translationally induced by hypoxia is involved in negative and positive feedback loops with HIF-1alpha. PLoS One 3: e3078.
44. Galy B, Creancier L, Prado-Lourenco L, Prats AC, Prats H, (2001) p53 directs conformational change and translation initiation blockade of human fibroblast growth factor 2 mRNA. Oncogene 20: 4613-4620.
45. Galy B, Creancier L, Zanibellato C, Prats AC, Prats H, (2001) Tumour suppressor p53 inhibits human fibroblast growth factor 2 expression by a post-transcriptional mechanism. Oncogene 20: 1669-1677.
46. Yuan L, Santi M, Rushing EJ, Cornelison R, MacDonald TJ, (2010) ERK activation of p21 activated kinase-1 (Pak1) is critical for medulloblastoma cell migration. Clin Exp Metastasis 27: 481-491.
47. Tang W, Wei Y, Le K, Li Z, Bao Y, et al. (2011) Mitogen-activated protein kinases ERK 1/2- and p38-GATA4 pathways mediate the Ang II-induced activation of FGF2 gene in neonatal rat cardiomyocytes. Biochem Pharmacol 81: 518-525.
48. Lefevre G, Babchia N, Calipel A, Mouriaux F, Faussat AM, et al. (2009) Activation of the FGF2/FGFR1 autocrine loop for cell proliferation and survival in uveal melanoma cells. Invest Ophthalmol Vis Sci 50: 1047-1057.
49. Zhong G, Fan P, Ji H, Dong F, Huang Y, (2001) Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J Exp Med 193: 935-942.
50. Kumar Y, Valdivia RH, (2008) Actin and intermediate filaments stabilize the Chlamydia trachomatis vacuole by forming dynamic structural scaffolds. Cell Host Microbe 4: 159-169.
51. Florkiewicz RZ, Majack RA, Buechler RD, Florkiewicz E, (1995) Quantitative export of FGF-2 occurs through an alternative, energy-dependent, non-ER/Golgi pathway. J Cell Physiol 162: 388-399.
52. Mignatti P, Morimoto T, Rifkin DB, (1992) Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J Cell Physiol 151: 81-93.
53. Keller M, Ruegg A, Werner S, Beer HD, (2008) Active caspase-1 is a regulator of unconventional protein secretion. Cell 132: 818-831.
54. Dahl JP, Binda A, Canfield VA, Levenson R, (2000) Participation of Na,K-ATPase in FGF-2 secretion: rescue of ouabain-inhibitable FGF-2 secretion by ouabain-resistant Na,K-ATPase alpha subunits. Biochemistry 39: 14877-14883.
55. Taverna S, Ghersi G, Ginestra A, Rigogliuso S, Pecorella S, et al. (2003) Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells. J Biol Chem 278: 51911-51919.
56. Lu H, Shen C, Brunham RC, (2000) Chlamydia trachomatis infection of epithelial cells induces the activation of caspase-1 and release of mature IL-18. J Immunol 165: 1463-1469.
57. Davis CH, Wyrick PB, (1997) Differences in the association of Chlamydia trachomatis serovar E and serovar L2 with epithelial cells in vitro may reflect biological differences in vivo. Infect Immun 65: 2914-2924.
58. Fadel S, Eley A, (2004) Chlorate: a reversible inhibitor of proteoglycan sulphation in Chlamydia trachomatis-infected cells. J Med Microbiol 53: 93-95.
59. Moelleken K, Hegemann JH, (2008) The Chlamydia outer membrane protein OmcB is required for adhesion and exhibits biovar-specific differences in glycosaminoglycan binding. Mol Microbiol 67: 403-419.
60. Eswarakumar VP, Lax I, Schlessinger J, (2005) Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 16: 139-149.
61. Hashimoto A, Kurosaki M, Gotoh N, Shibuya M, Kurosaki T, (1999) Shc regulates epidermal growth factor-induced activation of the JNK signaling pathway. J Biol Chem 274: 20139-20143.
62. Klint P, Kanda S, Claesson-Welsh L, (1995) Shc and a novel 89-kDa component couple to the Grb2-Sos complex in fibroblast growth factor-2-stimulated cells. J Biol Chem 270: 23337-23344.
63. Aloy P, Russell RB, (2006) Structural systems biology: modelling protein interactions. Nat Rev Mol Cell Biol 7: 188-197.
64. Yu PJ, Ferrari G, Pirelli L, Galloway AC, Mignatti P, et al. (2008) Thrombin cleaves the high molecular weight forms of basic fibroblast growth factor (FGF-2): a novel mechanism for the control of FGF-2 and thrombin activity. Oncogene 27: 2594-2601.
65. Lofmark S, de Klerk N, Aro H, (2011) Neisseria gonorrhoeae infection induces altered amphiregulin processing and release. PLoS One 6: e16369.
66. Dickson JH, Grabowska A, El-Zaatari M, Atherton J, Watson SA, (2006) Helicobacter pylori can induce heparin-binding epidermal growth factor expression via gastrin and its receptor. Cancer Res 66: 7524-7531.
67. Coombes BK, Chiu B, Fong IW, Mahony JB, (2002) Chlamydia pneumoniae infection of endothelial cells induces transcriptional activation of platelet-derived growth factor-B: a potential link to intimal thickening in a rabbit model of atherosclerosis. J Infect Dis 185: 1621-1630.
68. Zittermann SI, Issekutz AC, (2006) Basic fibroblast growth factor (bFGF, FGF-2) potentiates leukocyte recruitment to inflammation by enhancing endothelial adhesion molecule expression. Am J Pathol 168: 835-846.
69. Sorensen V, Nilsen T, Wiedlocha A, (2006) Functional diversity of FGF-2 isoforms by intracellular sorting. Bioessays 28: 504-514.
70. Pardo OE, Wellbrock C, Khanzada UK, Aubert M, Arozarena I, et al. (2006) FGF-2 protects small cell lung cancer cells from apoptosis through a complex involving PKCepsilon, B-Raf and S6K2. EMBO J 25: 3078-3088.
71. van Ooij C, Apodaca G, Engel J, (1997) Characterization of the Chlamydia trachomatis vacuole and its interaction with the host endocytic pathway in HeLa cells. Infect Immun 65: 758-766.
72. Caldwell HD, Kromhout J, Schachter J, (1981) Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun 31: 1161-1176.
73. Winer J, Jung CK, Shackel I, Williams PM, (1999) Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270: 41-49.